{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:45:44Z","timestamp":1668750344913},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,11,1]]},"DOI":"10.1001\/jamaophthalmol.2022.3824","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T15:40:27Z","timestamp":1665070827000},"page":"1094","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Hypertension and Anti\u2013Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity\u2014Is There a Link?"],"prefix":"10.1001","volume":"140","author":[{"given":"Samir N.","family":"Patel","sequence":"first","affiliation":[{"name":"Mid Atlantic Retina, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"eic220036r1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology.","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"key":"eic220036r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.3788","article-title":"Pulmonary hypertension in preterm infants treated with laser vs anti\u2013vascular endothelial growth factor therapy for retinopathy of prematurity.","author":"Nitkin","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"eic220036r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09286586.2022.2036766","article-title":"Association of cardiovascular disease with retinopathy of prematurity.","author":"Bhatti","year":"2022","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"eic220036r4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"10208","key":"eic220036r5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"eic220036r6","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jamaophthalmol.2020.0334","article-title":"Short-term outcomes after very low-dose intravitreous bevacizumab for retinopathy of prematurity.","volume":"138","author":"Wallace","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"eic220036r7","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.ophtha.2018.05.001","article-title":"A dosing study of bevacizumab for retinopathy of prematurity: late recurrences and additional treatments.","volume":"125","author":"Wallace","year":"2018","journal-title":"Ophthalmology"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2797008\/jamaophthalmology_patel_2022_ic_220036_1668089462.44067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T16:02:27Z","timestamp":1668700947000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2797008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.3824","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}